Notably, the frequencies of myositis and pleurisy were significantly higher in SLE patients who had high serum MPO-DNA than in those with low levels (Table 1) while the frequency of other clinical manifestations were not dependent on MPO-DNA complex levels. This evidence concerns the gene MPO and myositis disease.